chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tinge in my injection site right arm after the first Moderna Covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (tinge in my injection site right arm after the first Moderna Covid-19 vaccine) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (tinge in my injection site right arm after the first Moderna Covid-19 vaccine). At the time of the report, VACCINATION SITE DISCOLOURATION (tinge in my injection site right arm after the first Moderna Covid-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.  The patient had no adverse reaction after her second Moderna COVID-19 vaccine.
Student developed fever, cough, headache, vomiting, the following day after the vaccination on 11/23/09. Child seen @ hospital twice. Was given ZITHROMAX. Child was also taken to hospital by grandmother.
Fever x3days - Tmax 105.3-started evening of vaccination. emesis x2 day of vaccine. poor appetite x2 days very low energy x3days
On January 16th I started feeling very dizzy in my eyes got blurry  very dry mouth and palpitations, and I almost passed out at home, my husband had to take me to Er.  They wanted to keep me in the hospital but I told him I will follow up with my doctor on Monday, I did not want to stay on the floor with covid patients the test that they had ordered at the hospital were normal they did not order a CMP they only did a basic metabolic panel and that was normal, so I followed up with my doctor on Monday which was January 18th, and she ordered CMP and all the labs, when they threw my blood my liver enzymes were very elevated over the thousands LT ASG and the and others, then the doctor ordered a second set of blood works of CMP just to make sure it wasn't a fluke, they were even more elevated they were over 1,400.
UNABLE TO RISE UP ARM; KNOB LEFT ARM; LEFT SHOULDER PAIN; This spontaneous report received from a patient concerned a 78 year old female. The patient's height, and weight were not reported. The patient's past medical history included vitiligo, and pruritus, and concurrent conditions included diabetes mellitus, hypertension, severed leg cramps, osteoarthritis, venous reflux, sulfonamide allergy, iodine allergy, shellfish / lobster allergy, shrimp/ lemon/ pepper allergy, no alcoholic user, and non smoker, and other pre-existing medical conditions included the patient had no drug abuse or illicit drug usage.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1808980, and batch number: 1808980 expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 12:45 for prophylactic vaccination. No concomitant medications were reported. On 27-APR-2021, the subject experienced unable to rise up arm. On 27-APR-2021, the subject experienced knob left arm. On 27-APR-2021, the subject experienced left shoulder pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from left shoulder pain on 28-APR-2021, and had not recovered from knob left arm, and unable to rise up arm. This report was non-serious.
Case of misuse received from a physician on 16-MAY-2012, for VARIVAX (Merck), a Pregnancy Registry product. Case medically confirmed. A female adult patient received a dose of VARIVAX (Merck) (batch number, dose and route not reported) on 18-APR-2012 at the beginning of her pregnancy (LMP: 25-MAR-2012, EDD: 30-DEC-2012). Vaccination context: the patient's eldest son had chickenpox. Follow-up information received on 04-Jul-2012: The patient had a medical history of recurrent spontaneous abortions. She had one child. The patient did not undergo prenatal examination. She received the first dose of VARIVAX vaccine via the intramuscular route in the right deltoid. According to the reporter, the patient experienced no adverse reaction post-vaccination. She experienced a spontaneous abortion within 6 and a half weeks of amenorrhoea. Upon medical review the case was upgraded to serious on 04-Jul-2012 due to spontaneous abortion. Other business partner numbers include E2012-03207. Additional information is not expected.
Expired Moderna Covid-19 vaccine was administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine was administered) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine was administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine was administered) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported.  Patient received the booster dose of Moderna vaccine (Expiry date: 17-Apr-2022). The vial was initially stored in the refrigerator on 29-Apr-2022. Vial did not undergo any temperature excursions. No treatment medications were reported.
10-19-09 received shot. Within 2 days had swelling, redness and warm to touch.
Racing heart after walking the dog or simple tasks.  Weakness, nausea for a short time.
45 days have gone by after the first dose and the patient didn't receive her 2nd dose; A spontaneous report was received from a consumer concerning a 63-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and 2nd dose 45 days after 1st dose.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 05 Jan 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Batch Number: 011j20a) in left arm for prophylaxis of COVID-19 infection.  On 25 Feb 2021, 45 days have gone by after the first dose and the patient didn't receive her 2nd dose.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.  The outcome of the event patient didn't receive her 2nd dose 45 days have gone was considered recovered.; Reporter's Comments: This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273  with no associated AEs reported.
I am a type one diabetic and if I do a shot of NovoLog insulin in my left arm (the same arm I got my vaccine in), my body acts as if I took no insulin.  If I take a shot of NovoLog insulin in my right arm, legs, stomach, or buttocks, the insulin works like normal.  This same thing happened when I got my 1st dose of the Moderna Vaccine.  I did not realize this effect was happening right after I got the first dose of the vaccine, but when I look back at my diabetes blood sugar & insulin record, I clearly see the same effect.  Since I didn?t realize it, I took a shot of Novolog insulin in the same arm I got my 1st dose of vaccine once, an hour after I got the vaccine & it didn?t work.  Then I took a dose of Novolog insulin in the same arm as the vaccine 12 hours later and the insulin worked about half as well as it usually does.  The next day when I took a shot of Novolog insulin in the left arm, it worked like usual & it has worked like usual in that arm ever since, until I took a shot of Novolog insulin in the same arm that I got my 2nd dose of vaccine in, about 3 hours after the vaccine was administered.
starting at 6:30pm, extreme tiredness, muscle aches, fatigue, and mild arm pain were felt. duration 2 days 7pm severe chills causing teeth chattering, duration 1.5 hours 9:45 insomnia, duration 30 hours 10:30 pm nausea, duration 1 hour 11pm vomiting of entire stomach contents, duration 30 minutes
Patient stated that a few days after taking the vaccine she started to feel a swelling in her collar bone by the shoulder. Felt like a lump but very soft. She stated it feels like there is a liquid in it but doesn't hurt. She also stated it feels like a piece of fat but it was only noticed after she took the vaccine. No other c/o fever, body aches, chills, sob, cough. Due to this reaction patient contacted her PCP shortly after taking the 2nd vaccine where she was then evaluated under her armpit for any other lumps and the MD informed her that it will go away. Blood work was done at that time which came back normal. As of 5/26/21 patient still has this lump feeling. She went back to her pcp where she was informed that she needs to get a ultra sound done to see exactly what the lump is.   No medications were taken, patient had no pain.
Initial report received on 09/Mar/2006 form a health care provider. A 43-year-old female patient with no significant past medical history, had received an intra-muscular injection of DECAVAC, lot number U16176A, in the left deltoid. Fifteen days later, the patient developed muscle aches and stiffness with limited range of motion in the left arm. At the time of this report, the patient had not recovered form these events. Follow-up received on 07/Apr/2006 from the responsible physician. The patient was seen by a physician for the event on 08/Mar/2006 and has recovered. No further information expected. The reporter for this case is the same as for case 2006-00580. A corrective version for this case was created on 13/sep/2006 to correct the lot number in the narrative section to U1617GA. No new information was received.
Patient c/o face tingling.  Face swelled significantly.  He ended up in the ER.  He received Iv steroids and Benadryl.
DTaP and MMR was administered on 03/07/2002. On 03/05/2002, the pt developed swelling, erythema, and intense itch of the right arm (DTaP arm). Then over the next 24 hours she had 6 episodes of knee and toe pain, with 2-3 episodes of stomach pain.
She had no problems except injection site soreness with the first one; This is a spontaneous report received from a contactable reporter (Consumer) for a Pfizer sponsored program. The reporter is the patient.  A 67 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 19Apr2021 (Lot number: EW0161) at the age of 67 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "She had no problems except injection site soreness with the first one". No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021585244 same patient, different drug/event
Initial unsolicited report received from a consumer on 19-March-2015. A 12-year-old female patient whose medical history included asthma diagnosis and concomitant medications not reported, had received a first dose of YF VAX via subcutaneous route in the left deltoid (batch number: UH841AA and expiry date: 7 February 2016) and TYPHIM VI via intramuscular route in the left deltoid (batch number: J1201 and expiry date: 14 April 2015) on 18-March-2015. On 18-March-2015 fifteen minutes after vaccination, the patient experienced vomiting and one hour after vaccination the patient experienced hives. The patient required ER/doctor visit. Corrective treatment and laboratory investigations were not reported. On 19-March-2015, the outcome of above mentioned events were recovered. Documents held by sender: none.
lt arm-swollen, hive-like, cellulitis-looking, not warm though, localized only; no fever, no swollen glands; pt was seen by school nurse on 30NV04; school nurse reported 30NOV04; 1130AM; referred pt to MD; induration area about 60 cm x 60cm
Patient states as she was walking out of the office after receiving the vaccine she felt flush in her face, warmth in her chest and had chest pain. She continued back up to her work area and completed her shift indicating that the chest pain receded to a slight tingling in her chest and that the redness in her face went away but her ears remained red.
A few seconds after I took the vaccine shot I felt pressure in my chest area, as if i was having anxiety  or a panic attack without being anxious. I felt like my heart rate increased. There was also muscle pressure in my jaws.  The chest pressure disappeared after a few minutes and my heart rate calmed down.
This spontaneous report was received from a nurse and refers to an unspecified number of patients of unknown demographics. No medical history, concurrent conditions or concomitant therapies were reported. On unknown dates, the patiens were vaccinated with improperly stored doses of RECOMBIVAX HB (lot #, doses, route of administration and anatomical location were not provided). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected, as the reporter did not wish to be contacted.
This case was reported by a non-health professional via call center representative and described the occurrence of feeling unwell in a 63-year-old female patient who received SHINGRIX (batch number TP5E5, expiry date 15th November 2020) for prophylaxis. On 18th June 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 18th June 2018, less than a day after receiving SHINGRIX, the patient experienced feeling unwell, sleeplessness, feeling hot, feeling cold, headache, pain in arm and erythema. On 19th June 2018, the outcome of the headache was recovered/resolved. On 21st June 2018, the outcome of the erythema was recovered/resolved. On an unknown date, the outcome of the feeling unwell, sleeplessness, feeling hot, feeling cold and pain in arm were unknown. It was unknown if the reporter considered the feeling unwell, sleeplessness, feeling hot, feeling cold, headache, pain in arm and erythema to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX in the right deltoid. The patient called the office to report how she felt after receiving the SHINGRIX vaccine. The patient felt ill, could not sleep, had headache for 1 day, redness for 4 days and sore arm.
This is a spontaneous report from a contactable nurse via a Pfizer sales representative. This nurse reported the same event for two patients. This is second of two reports. A 17-year-old male patient of an unspecified ethnicity received the first single dose of TRUMENBA, on 19May2016. 15 minutes later the patient fainted. The outcome of the event was unknown.
Site of injection, hot, red, itching. Felt tired, run down, checked blood pressure and it was around 186/97 and remained elevated for about 2 weeks. Pt. normally had good BP.
patient fainted, fell off chair and hit head on wall   we had him lie down on floor, took his blood pressure and put ice pack on bump on his head   he eventually sat up and felt better
Patient developed flu symptoms, fever and chills several hours after getting the vaccine. He had no prior symptoms. He had a high fever during that night and a lower grade fever through Saturday evening. He also had a sore throat and was very lethargic. His fever broke on Sunday and continued to have a sore throat. Today is Thursday and still has a cough.
Les than 24 hrs. after second does: bad headache, chills, sweats, body aches, pains, vomiting, diarrhea, weakness, sever fatigue, trouble breathing for week and a Half. Was admitted to ER by family doctor.
This spontaneous report was received from a healthcare worker and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date, the patient was vaccinated with an improperly stored dose of VARIVAX lot # M042858, expiration date 21-OCT-2018 (dose and route of administration were not reported). Concomitant therapies included properly stored sterile diluent (manufacturer unknown), which was used to reconstitute the vaccine. There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursions of: -14 to -10 degrees Celsius for 3 hours and 45 minutes; -9 to 8 degrees Celsius for 3 hours and 30 minutes. There were no previous temperature excursions reported. Data logger was involved.  No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1705USA008347:
On 2/5/13 pt. presented with (L) arm pain - states pain began when #2 GARDASIL vaccine was given on 12/18/12.
Patient is a 72 y.o. male admitted to the hospital on 12/27/2022 for complaints of cough, dyspnea, chills and was subsequently found to have COVID with suspected CAP and COPD exacerbation.  He was noted on admission to have a severe sepsis without shock as well.  Given his oxygen requirements he was started on steroids and an E consult was placed to infectious disease who recommended initiation of remdesivir.  He had a trace elevated Pro-Cal and given his complaints of thick sputum he has been treated for community-acquired pneumonia as well.  He did have signs of COPD exacerbation on admission in which was also started on appropriate regimen. Of note, he does have chronic hypoxic respiratory failure with suspected prescribed continuous 2 L of oxygen but reports wearing 2-3 only in the evening hours and at night.  He has a average SPO2 around 90% at rest and reports his oxygen levels normally are in the low 80s with activity and takes about 10 minutes for full recovery at baseline.  He was weaned off of supplemental oxygen and a walking oxygen test does reflect his home oxygen levels.  He has no respiratory distress on discharge and has no signs of continued acute exacerbation. He will continue on oral prednisone for 6 additional days for COVID as well as COPD treatment.  He only has 1 more additional day of Zithromax and Omnicef for CAP coverage. I recommended that he follow-up with his primary care provider and also pulmonary.  I recommend that he have follow-up for full explanation of prescribed home O2 needs and anything additional from a pulmonary perspective for chronic home regimen.
Date of Admission:                10/21/2022 Date of Discharge:                10/27/2022 Discharge Diagnoses: Active Hospital Problems   Diagnosis o Principal Problem: COVID-19 o (HFpEF) heart failure with preserved ejection fraction (CMS/HCC) o Acute respiratory failure with hypoxia (CMS/HCC) o Thrombocytopenia (CMS/HCC) o Pericardial effusion o End stage renal failure on dialysis (CMS/HCC) o Anemia due to chronic kidney disease, on chronic dialysis (CMS/HCC) o Hypoxia o Obesity (BMI 30-39.9) o Normocytic anemia o Fatty liver o Essential hypertension o Type 2 diabetes mellitus with chronic kidney disease on chronic dialysis, with long-term current use of insulin (CMS/HCC) o Acquired hypothyroidism o Bipolar affect
1/19/2021 vaccination. Felt flu like symptoms, body aches, feverish.  I reported to every day on health check-in. Muscle spasms, diarrhea, could not keep down water, HA, fatigue, lethargic. I thought I was dying.   1/21 0400am ER 1/22 ER 1/23 ER 1/24 ER; admitted inpatient to hospital. 11 Days inpatient.  Nausea, vomiting, diarrhea, feverish, malaise, gastric spasms, HA,  *12/2020 Gastrectomy  *Symptoms lasted whole duration in hospital. Could not keep any liquids down.
redness around the injection site; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A 65-year-old patient received pneumococcal 20-valent conjugate vaccine (diphtheria CRM197 protein) (PREVNAR 20), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), outcome "unknown", described as "redness around the injection site". Additional information: Patient has redness about 3 fingers down the injection site.  The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.
On 10th day injection site hurt again soreness and a rash developed  about size of baseball was not to red and didn?t really itch Was warm to touch read about it on line put compresses  as suggested and it went away in another 4-5 days
At 2:15 PM, student c/o itching around the face, 2-3 hives noted on right jaw, localized reaction noted at injection site, ice pack applied, lungs clear, denies itching in throat area, no swelling noted on face or lips. Attempted to call father, message left on cellphone. At 2:20 PM, 30mg IM Bendadryl given.  At 2:25PM P78, BP 120/70 denies tingling, numbness of tongue and mouth, respirations even and non-labored, 20/min.  At 2:30 PM Student states she is not itching anymore, injection site less reddened At 2:35 PM, spoke to grandmother and explained situation and asked her to try to reach parents. At 3:05PM, mother here to pick up student, instructions given to mother and what s/s to watch for. Student says itching is gone, respirations even and non-labored.
I did not have an adverse event after the vaccine other than a sore arm, however in 07MAR2023 I started to develop a new health problem, I had a pain in my left ear that started as a headache and then centralized more in the left ear. I called my PCP on 21MAR2023 when the pain became to great and was told I have a Eustachian tube dysfunction. I was treated with antibiotics and steroids but the problem is still ongoing and I have been referred to an ENT, I have not seen that provider yet.